NEW YORK (GenomeWeb News) — MDS this week filed with the Toronto Stock Exchange to buy back up to 4.5 million of its common shares over the next 12 months.
 
The potential buyback relates to MDS’ shares that trade on the Toronto exchange and will not affect the company’s shares that trade on the New York Stock Exchange.
 
As of June 26, MDS had 122.5 million shares issued and outstanding on the Toronto Stock Exchange.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.